Annual Statements Open main menu

ZYNEX INC - Quarter Report: 2024 September (Form 10-Q)

30

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    

ZYNEX, INC.

 

/s/ Daniel J. Moorhead

 Dated: October 24, 2024

Daniel J. Moorhead

 

Chief Financial Officer

 

(Principal Financial and Accounting Officer)

31

Similar companies

See also Medtronic plc - Annual report 2023 (10-K 2023-04-28) Annual report 2023 (10-Q 2023-07-28)
See also MASIMO CORP - Annual report 2022 (10-K 2022-12-31) Annual report 2023 (10-Q 2023-09-30)
See also LivaNova PLC - Annual report 2022 (10-K 2022-12-31) Annual report 2023 (10-Q 2023-09-30)
See also CONMED Corp - Annual report 2022 (10-K 2022-12-31) Annual report 2023 (10-Q 2023-09-30)
See also InMode Ltd.